Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR
Jeanetta W Frye, David A Peura Division of Gastroenterology and Hepatology, University of Virginia Health Sciences Center, Charlottesville, VA, USA Abstract: The management of gastroesophageal reflux disease (GERD) has been revolutionized with the development of proton pump inhibitors (PPIs). Unfo...
Main Authors: | Frye JW, Peura DA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | https://www.dovepress.com/managing-gastroesophageal-reflux-diseasenbspndash-comparative-efficacy-peer-reviewed-article-TCRM |
Similar Items
-
Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux disease
by: Kukulka M, et al.
Published: (2014-12-01) -
The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease
by: Ronnie Fass, et al.
Published: (2017-02-01) -
The Effect of Dexlansoprazole on Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
by: Gabriel Pereira Nunes, et al.
Published: (2024-01-01) -
The strategy for choosing a new-generation proton pump inhibitor dexlansoprazole in the treatment of gastroesophageal reflux disease
by: N. V. Topchiy, et al.
Published: (2018-04-01) -
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
by: Mermelstein J, et al.
Published: (2016-07-01)